<p>Cytotoxicity was determined by quantifying the percentage of LDH release relative to the maximum LDH release of untreated spheroid cultures. The results were presented as means ± S.E.M. of three independent experiments.</p
We developed a three-dimensional assay prepared from primary breast cancer tissue and quantified tum...
<p><b>A)</b> HSFs were treated with MTX at a concentration of 1μM or 10μM for 24 hours. Percentage o...
Tamoxifen, a potent anticancer agent known to interrupt the enhanced estrogen activity of malignant ...
<p>Monolayer and MCTS cultures of the MCF-7 cell line were exposed to tamoxifen for 4 days. MTT assa...
In comparison to monolayer cells, MCTS has been claimed as more suitable candidate for studying drug...
<p>Relative to the untreated control, which was normalized to 0% in both assays, reduction in cell v...
In comparison to monolayer cells, MCTS has been claimed as more suitable candidate for studying drug...
*<p>Statistical significance (P<0.05) between control cells and treatment groups.</p
<p>TR-MCF7 and parental MCF7 cells were treated for 48 hours in with 10 µM YM-1. After 48 hours, med...
Aim: To investigate the cytotoxic effects of tamoxifen on the breast cancer cell line (MCF7).Methods...
<p>MCF-7 cells were cultured in presence of 1% FBS during 24 hours in the absence or presence PUGNAc...
Tamoxifen (TAM) is a non-steroidal anti-estrogen used to treat patients with estrogen receptor-posit...
Tamoxifen citrate (TAM) has been used to treat breast cancer in women for many years. The com-parati...
Tamoxifen (TAM) is a non-steroidal anti-estrogen used to treat patients with estrogen receptor-posit...
<p>MCF-7(LCC1), LCC2, LCC9, R27 and BT474 cells were treated with 0 to 10 µM of tamoxifen for 6 days...
We developed a three-dimensional assay prepared from primary breast cancer tissue and quantified tum...
<p><b>A)</b> HSFs were treated with MTX at a concentration of 1μM or 10μM for 24 hours. Percentage o...
Tamoxifen, a potent anticancer agent known to interrupt the enhanced estrogen activity of malignant ...
<p>Monolayer and MCTS cultures of the MCF-7 cell line were exposed to tamoxifen for 4 days. MTT assa...
In comparison to monolayer cells, MCTS has been claimed as more suitable candidate for studying drug...
<p>Relative to the untreated control, which was normalized to 0% in both assays, reduction in cell v...
In comparison to monolayer cells, MCTS has been claimed as more suitable candidate for studying drug...
*<p>Statistical significance (P<0.05) between control cells and treatment groups.</p
<p>TR-MCF7 and parental MCF7 cells were treated for 48 hours in with 10 µM YM-1. After 48 hours, med...
Aim: To investigate the cytotoxic effects of tamoxifen on the breast cancer cell line (MCF7).Methods...
<p>MCF-7 cells were cultured in presence of 1% FBS during 24 hours in the absence or presence PUGNAc...
Tamoxifen (TAM) is a non-steroidal anti-estrogen used to treat patients with estrogen receptor-posit...
Tamoxifen citrate (TAM) has been used to treat breast cancer in women for many years. The com-parati...
Tamoxifen (TAM) is a non-steroidal anti-estrogen used to treat patients with estrogen receptor-posit...
<p>MCF-7(LCC1), LCC2, LCC9, R27 and BT474 cells were treated with 0 to 10 µM of tamoxifen for 6 days...
We developed a three-dimensional assay prepared from primary breast cancer tissue and quantified tum...
<p><b>A)</b> HSFs were treated with MTX at a concentration of 1μM or 10μM for 24 hours. Percentage o...
Tamoxifen, a potent anticancer agent known to interrupt the enhanced estrogen activity of malignant ...
DOI
Add to ORKG